CONVERSION LABS, INC. Uncategorized Contracts & Agreements
36 Contracts & Agreements
- Director Agreement, dated April 26, 2024, between LifeMD, Inc. and Calum MacRae (Filed With SEC on May 2, 2024)
- Director Agreement, dated June 20, 2023 between LifeMD, Inc. and William J. Febbo (Filed With SEC on June 22, 2023)
- Director Agreement, dated February 9, 2023 between LifeMD, Inc. and Joan LaRovere (Filed With SEC on February 10, 2023)
- Director Agreement, dated December 15, 2022, between LifeMD, Inc. and Kate Walsh (Filed With SEC on December 21, 2022)
- Director Agreement, dated September 14, 2022, between LifeMD, Inc. and Robert Jindal (Filed With SEC on September 20, 2022)
- Description of Securities (Filed With SEC on March 7, 2022)
- Renewed Director Agreement, dated September 21, 2021, by and between LifeMD, Inc. and Dr. Joseph V. DiTrolio (Filed With SEC on November 10, 2021)
- Renewed Director Agreement, dated September 20, 2021, by and between LifeMD, Inc. and Dr. Eleanor C. Mariano (Filed With SEC on November 10, 2021)
- Renewed Director Agreement, dated September 7, 2021, by and between LifeMD, Inc. and John Strawn (Filed With SEC on November 10, 2021)
- Director Agreement between LifeMD, Inc. and Naveen Bhatia, dated September 8, 2021 (Filed With SEC on September 13, 2021)
- Renewed Director Agreement between LifeMD, Inc. and Roberto Simon, dated July 30, 2021 (Filed With SEC on August 4, 2021)
- Description of Securities (Filed With SEC on March 30, 2021)
- Pathak Option Agreement (Filed With SEC on January 28, 2021)
- Fitzpatrick Option Agreement (Filed With SEC on January 28, 2021)
- Form of Founding Members MIPA (Filed With SEC on January 26, 2021)
- Form of CVLB PR MIPA (Filed With SEC on January 26, 2021)
- Form of Non-Qualified Option Agreement (Employee Awards) (Filed With SEC on January 14, 2021)
- Form of Non-Qualified Option Agreement (Non-Employee Director Awards) (Filed With SEC on January 14, 2021)
- Director Agreement, dated November 6, 2020 (Filed With SEC on November 10, 2020)
- Form of Lock-Up Agreement (Filed With SEC on November 4, 2020)
- Director Agreement, dated October 21, 2020 (Filed With SEC on October 22, 2020)
- Fitzpatrick Amendment by and between the Company and Mr. Sean Fitzpatrick (Filed With SEC on January 24, 2020)
- Form of Lock-Up Agreement (Filed With SEC on August 19, 2019)
- Strategic Partnership Agreement, dated May 31, 2019, by and between Conversion Labs RX, LLC and Specialty Medical Drugstore (d/b/a GoGo Meds) (Filed With SEC on June 7, 2019)
- Form of Lock-Up Agreement (Filed With SEC on June 1, 2018)
- Agreement with JOJ Holdings, LLC dated as of November 20, 2017 (Filed With SEC on November 27, 2017)
- Director Agreement with Dr. Michael Borenstein, dated October 1, 2017 (Filed With SEC on October 12, 2017)
- Director Agreement with John Strawn, dated July 1, 2017 (Filed With SEC on August 14, 2017)
- Director Agreement with Anthony Bruzzese, dated July 1, 2017 (Filed With SEC on August 14, 2017)
- Director Agreement with Stefan Gallupi, dated July 24, 2017 (Filed With SEC on August 14, 2017)
- Director Agreement with Justin Schreiber, dated July 24, 2017 (Filed With SEC on August 14, 2017)
- DIRECTOR AGREEMENT (Filed With SEC on March 30, 2015)
- 3470 South Clinton Ave., South Plainfield,NJ 07080 ###-###-#### (Filed With SEC on January 23, 2013)
- DESCRIPTION OF ROYALTY AGREEMENT BETWEEN IMMUDYNE, INC. AND MARK MCLAUGHLIN (Filed With SEC on December 5, 2012)
- DIRECTOR AGREEMENT (Filed With SEC on October 18, 2012)
- DIRECTOR AGREEMENT (Filed With SEC on October 18, 2012)
